SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs

Eur J Immunol. 2022 Apr;52(4):646-655. doi: 10.1002/eji.202149656. Epub 2022 Feb 16.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), an infectious disease characterized by strong induction of inflammatory cytokines, progressive lung inflammation, and potentially multiorgan dysfunction. It remains unclear how SARS-CoV-2 infection leads to immune activation. The Spike (S) protein of SARS-CoV-2 has been suggested to trigger TLR4 and thereby activate immunity. Here, we have investigated the role of TLR4 in SARS-CoV-2 infection and immunity. Neither exposure of isolated S protein, SARS-CoV-2 pseudovirus nor primary SARS-CoV-2 isolate induced TLR4 activation in a TLR4-expressing cell line. Human monocyte-derived DCs express TLR4 but not angiotensin converting enzyme 2 (ACE2), and DCs were not infected by SARS-CoV-2. Notably, neither S protein nor SARS-CoV-2 induced DC maturation or cytokines, indicating that both S protein and SARS-CoV-2 virus particles do not trigger extracellular TLRs including TLR4. Ectopic expression of ACE2 in DCs led to efficient infection by SARS-CoV-2 and, strikingly, efficient type I IFN and cytokine responses. These data strongly suggest that not extracellular TLRs but intracellular viral sensors are key players in sensing SARS-CoV-2. These data imply that SARS-CoV-2 escapes direct sensing by TLRs, which might underlie the lack of efficient immunity to SARS-CoV-2 early during infection.

Keywords: Dendritic cells; Innate immune response; Intracellular viral sensors; SARS-CoV-2; Toll-like receptor 4.

MeSH terms

  • COVID-19* / immunology
  • Cell Line
  • Dendritic Cells* / immunology
  • Humans
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus* / immunology
  • Toll-Like Receptor 4* / immunology

Substances

  • Spike Glycoprotein, Coronavirus
  • TLR4 protein, human
  • Toll-Like Receptor 4
  • spike protein, SARS-CoV-2